Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) Levels
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pulmonary Embolism
Related studies linked through entity extraction aliases.
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism
- Status
- COMPLETED
- Phase
- PHASE4
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
- Status
- COMPLETED
- Phase
- PHASE3
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Outpatient Treatment for Pulmonary Embolism
- Status
- COMPLETED
- Phase
- PHASE3
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
- Status
- COMPLETED
- Phase
- PHASE3
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
- Status
- COMPLETED
- Phase
- NA
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
- Status
- COMPLETED
- Phase
- NA
Multi-Center Human Alert Trial to Prevent DVT and PE
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism
- Status
- COMPLETED
- Phase
- N/A
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
- Status
- COMPLETED
- Phase
- NA
Deferment of Imaging for Pulmonary Embolism
- Status
- COMPLETED
- Phase
- PHASE4
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
- Status
- WITHDRAWN
- Phase
- N/A
Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Breath Analysis Technique to Diagnose Pulmonary Embolism
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
- Status
- COMPLETED
- Phase
- PHASE4
Detection of Pulmonary Embolism With CECT
- Status
- COMPLETED
- Phase
- PHASE4
A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
- Status
- COMPLETED
- Phase
- NA